Overview: Allergy Alder TestIntroduction: The Allergy Alder Test detects IgE antibodies to alder (bhidur) pollen, which may cause sneezing, runny nose, or itchy eyes during pollen season. Following 2023 AAAAI guidelines, it uses an immunoassay for high sensitivity, aiding in confirming pollen allergies. This test is essential for guiding avoidance strategies or immunotherapy, preventing allergic reactions, and improving outcomes in allergology.
Other Names: Allergy Alder Assay, Alder IgE Test.
FDA Status: Laboratory-developed test (LDT) meeting allergology standards for diagnostic accuracy.
Historical Milestone: Pollen allergy testing started in the 1960s with skin tests. Immunoassays for specific IgE emerged in the 1980s, and by the 2000s, advanced fluorescence-based assays improved specificity for allergens like alder pollen.
Purpose: Diagnoses alder pollen allergies, guides avoidance or immunotherapy, and monitors allergic responses in patients with respiratory or ocular symptoms.
Test Parameters: 1. Alder IgE
Pretest Condition: No fasting required. Collect serum or saliva at any time, preferably during pollen season or symptom onset. Report symptoms like sneezing, itchy eyes, or alder pollen exposure. List medications such as antihistamines or corticosteroids.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours to preserve sample integrity.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document allergic symptoms (e.g., sneezing, runny nose, itchy eyes), pollen exposure history, or family history of allergies. Include current medications, particularly antihistamines or immunotherapy.
Consent: Written consent required, explaining the tests purpose, diagnostic implications, and potential need for avoidance or immunotherapy.
Procedural Considerations: Employs an immunoassay (e.g., fluorescence enzyme immunoassay) to measure alder-specific IgE. Results are available in 1-2 days, supporting rapid diagnosis.
Factors Affecting Result Accuracy: Antihistamines or corticosteroids may suppress IgE levels, causing false negatives. Hemolysis or improper storage can degrade samples. Testing outside pollen season may reduce sensitivity.
Clinical Significance: Elevated alder-specific IgE confirms allergy, prompting avoidance or immunotherapy. Normal levels may require skin testing or clinical correlation to rule out allergy.
Specialist Consultation: Consult an allergist for result interpretation. Immunotherapy specialists are advised for severe cases.
Additional Supporting Tests: Skin prick test, total IgE, or pollen panel to confirm alder allergy or identify cross-reactive allergens.
Test Limitations: False negatives may occur with antihistamine use or low pollen exposure. Cross-reactivity with birch pollen requires clinical correlation.
References: AAAAI Allergy Guidelines, 2023; Allergy, Dreborg S, 2022.
